New developments in imaging in rheumatoid arthritis

Current Opinion in Rheumatology

Volumn 15, Issue 3, 2003, Pages 288-295

  Peterfy, Charles G ^a  

^a SYNARC INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM; LEFLUNOMIDE; METHOTREXATE; PENTETIC ACID;

ARTICULAR CARTILAGE; BONE EROSION; CLINICAL EXAMINATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIGITAL RADIOGRAPHY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; DOPPLER FLOWMETER; FOLLOW UP; HISTOLOGY; HUMAN; IMAGE ENHANCEMENT; IMAGING SYSTEM; KINETICS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REAL TIME ECHOGRAPHY; REVIEW; RHEUMATOID ARTHRITIS; SYNOVITIS;

ARTHRITIS, RHEUMATOID; ARTHROGRAPHY; DIAGNOSTIC IMAGING; FEMALE; FORECASTING; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0038746716     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200305000-00017     Document Type: Review

References (79)

1. Peterfy CG: The role of MR imaging in clinical research studies. Semin Musculoskeletal Radiol 2001, 5:365-378.
2. Irvine S, Munro R, Porter D: Early referral, diagnosis, and treatment of rheumatoid arthritis: evidence for changing medical practice. Ann Rheum Dis 1999, 58:510-513.
3. Emery P: Evidence supporting the benefit of early intervention in rheumatoid arthritis. J Rheumatol 2002, 29(suppl 66):3-6.
4. Peterfy C: Imaging techniques. In Rheumatology vol. 1, edn 2. Edited by Klippel J, Dieppe P, eds. Philadelphia: Mosby, 1997:14.1-14.18.
5. Swinkels HL, Laan RFJM, van't Hof MA, et al.: Modified Sharp method: factors influencing reproducibility and variability. Seminars Arthritis Rheum 2001, 31:176-190.
6. van der Heijde DMFM: How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 1999, 26:743-745.
7. Bruynesteyn K, van der Heijde D, Boers M, et al.: Determination of the minimal clinically important difference in rheumatoid arthritis joint damage of the Sharp/van der Hejde and Larson/Scott scoring methods by clinical experts and comparison with the smallest detectable difference. Arthritis Rheum 2002, 46:913-920. This article illustrates the rationale and implications of determining SDD and MCID for imaging markers in clinical trials.
8. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 1:307-310.
9. Bland JM, Altman DG: Measurement error. BJM 1996, 313:744.
10. Lassere M, Boers M, van der Hejde D, et al.: Smallest detectable difference in radiologic progression. J Rheumatol 1999, 26:731-739.
11. Bruynesteyn K, van der Hejde D, Boers M, et al.: Detecting radiologic changes in rheumatoid arthritis that are considered important by clinical experts: Influence of reading with or without known sequence. J Rheumatol 2002, 29:2306-2312. This article illustrates how the approach taken to reading radiographs in clinical trials can affect the results.
12. Wassenberg S, Rau R: Radiographic healing with sustained clinical remission in a patient with rheumatoid arthritis receiving methotrexate monotherapy. Arthritis Rheum 2002, 46:2804-2807.
13. Rau R, Wassenberg S, Herborn G, et al.: Identification of radiologic healing phenomena in patients with rheumatoid arthritis. J Rheumatol 2001, 28:2608-2615.
14. Machold KP, Stamm TA, Eberl GJM, et al.: Very recent onset arthritis: clinical, laboratory, and radiologic findings during the first year of disease. J Rheumatol 2002, 29:2278-2287.
15. McQueen FM, Benton N, Crabbe J, et al.: What is the fate of erosions in early rheumatoid arthritis? Tracking individual lesions using x-rays and magnetic resonance imaging over the first two years of disease. Ann Rheum Dis 2001, 60:859-868.
16. Budinger T, Lauterbur P: Nuclear magnetic resonance technology for medical studies. Science 1984, 226:288-298.
17. Pykett I: NMR imaging in medicine. Sci Am 1982, 246:78-88.
18. Jorgensen C, Cyteval C, Anaya J, et al.: Sensitivity of magnetic resonance imaging of the wrist in very early rheumatoid arthritis. Clin Exp Rheumatol 1993, 11:163-168.
19. McQueen F, Stewart N, Crabbe J, et al.: Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at four months after symptom onset. Ann Rheum Dis 1998, 57:350-360.
20. Peterfy C, Dion E, Miaux Y, et al.: Comparison of MRI and x-ray for monitoring erosive changes in rheumatoid arthritis. Arthritis Rheum 1998, 41(suppl):S51.
21. Østergaard M, Hansen M, Stolenberg M, et al.: Magnetic resonance imaging-determined synovial membrane volume as a marker of disease activity and a predictor of progressive joint destruction in the wrists of patients with rheumatoid arthritis. Arthritis Rheum 1999, 42:918-929.
22. Klarlund M, Østergaard M, Gideon P, et al.: Wrist and finger joint MR imaging in rheumatoid arthritis. Acta Radiol 1999, 40:400-409.
23. Foley-Nolan D, Stack J, Ryan M, et al.: Magnetic resonance imaging in the assessment of rheumatoid arthritis: a comparison with plain film radiographs. Br J Rheumatol 1991, 30:101-106.
24. McGonagle D, Conaghan PG, O'Connor P, et al.: The relation between synovitis and bone changes in early untreated rheumatoid arthritis: a controlled magnetic resonance imaging study. Arthritis Rheum 1999, 42:1706-1711.
25. Østergaard M, Gideon P, Sorenson K, et al.: Scoing of synovial membrane hypertrophy and bone erosions by MR imaging and clinically active and inactive rheumatoid arthritis of the wrist. Scand J Rheumatol 1995, 24:212-218.
26. Emery P, Luqmani R: The validity of surrogate markers in rheumatic disease. Br J Rheumatol 1993, 32(suppl 3):3-8.
27. Lindegaard H, Vallø J, Høslev-Petersen K, et al.: Low field dedicated magnetic resonance imaging in untreated rheumatoid arthritis of recent onset. Ann Rheum Dis 2001, 60:770-776. This article offers a good illustration of potential utility of small dedicated extremity MRI systems.
28. Backhaus M, Burmester GR, Sandrock D, et al.: Prospective two year follow up study comparing novel and conventional imaging procedures in patients with arthritic finger joints. Ann Rheum Dis 2002, 61:895-904.
29. Peterfy CG, Roberts T, Genant HK: Dedicated extremity MRI: an emerging technology. In Radiol Clin N Am, vol 35. Edited by Kneeland JB. Philadelphia, PA: WB Saunders, 1996:1-20.
30. Lee JK, Yao L, Wirth CR: MR imaging of solitary osteochondroma: report of eight cases. AJR 1987, 149:557-560.
31. McQueen FM: Magnetic resonance imaging in early arthritis: what is its role? Rheumatol 2000, 39:700-706.
32. McQueen F, Stewart N, Crabbe J, et al.: Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals progression of erosions despite clinical improvement. Ann Rheum Dis 1999, 58:156-163.
33. Feller JF, Rishi M, Hughes EC: Lipoma arborescens of the knee: MR demonstration. AJR 1994, 163:162-164.
34. Peterfy CG, Majumdar S, Lang P, et al.: MR imaging of the arthritic knee: improved discrimination of cartilage, synovium and effusion with pulsed saturation transfer and fat-suppressed T1-weighted sequences. Radiology 1994, 191:413-419.
35. Smith H-J, Larheim TA, Aspestrand F: Rheumatic and nonrheumatic disease in the temporomandibular joint: gadolinium-enhanced MR imaging. Radiology 1992, 185:229-234.
36. Drapé J-L, Thelen P, Gay-Depassier P, et al.: Intraarticular diffusion of Gd-DOTA after intravenous injection in the knee: MR imaging evaluation. Radiology 1993,188:227-234.
37. Yamato M, Tamai K, Yamaguchi T, et al.: MRI of the knee in rheumatoid arthritis: Gd-DTPA perfusion dynamics. J Comput Assist Tomogr 1993, 17:781-785.
38. Winalski CS, Aliabadi P, Wright RJ, et al.: Enhancement of joint fluid with intravenously administered gadopentetate dimeglumine: technique, rationale, and implications. Radiology 1993, 187:197-185.
39. Jevtic V, Watt I, Rozman B, et al.: Precontrast and postcontrast (Gd-DTPA) magnetic resonance imaging of hand joints in patients with rheumatoid arthritis. Clin Radiol 1993, 48:176-181.
40. Jevtic V, Watt I, Rozman B, et al.: Distinctive radiologic features of small hand joints in rheumatoid arthritis and seronegative spondyloarthritis demonstrated by contrast-enhanced (Gd-DTPA) magnetic resonance imaging. Skeletal Radiol 1995, 24:351-355.
41. Klarlund M, Østergaard M, Rostrup E, et al.: Dynamic magnetic resonance imaging of the metacarpophalangeal joints in rheumatoid arthritis, early unclassified polyarthritis and healthy controls. Scand J Rheumatol 2000, 29:108-115.
42. Østergaard M, Hansen M, Stoltenberg M, et al.: Quantitative assessment of the synovial membrane in the rheumatoid wrist: an easily obtained MRI score reflects the synovial volume. Br J Rheumatol 1996, 35:965-971.
43. Østergaard M, Stoltenberg M, Lovgreen-Nielsen P, et al.: Magnetic resonance imaging-determined synevial membrane and joint effusion volumes in rheumatoid arthritis and osteoarthritis: comparison with the macroscopic and microscopic appearance of the synovium. Arthritis Rheum 1997, 40:1856-1867.
44. Savnik A, Malmskov H, Thomasen HS, et al.: MRI of the arthritic small joints: comparison of extremity MRI (0.2 T) vs high-field MRI (1.5 T). Eur Radiol 2001, 11:1030-1038.
45. Palmer WE, Rosenthal DI, Shoenberg OI, et al.: Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1995, 196:645-655.
46. Sugimoto H, Takeda A, Kano S: Assessment of disease activity in rheumatoid arthritis using magnetic resonance imaging: quantification of pannus volume in the hands. Br J Rheumatol 1998, 37:854-861.
47. Huang J, Stewart N, Crabbe J, et al.: A 1-year follow-up study of dynamic magnetic resonance imaging in early rheumatoid arthritis reveals synovitis to be increased in shared epitope-positive patients and predictive of erosions at 1 year. Rheumatology 2000, 39:407-416.
48. Savnik A, Malmskov H, Thomasen HS, et al.: MRI of the wrist and finger joints in inflammatory joint diseases at 1-year interval: MRI features predict bone erosions. Eur Radiol 2002, 12:1203-1210.
49. Tamai K, Yamato M, Yamaguchi T, et al.: Dynamic magnetic resonance imaging for the evaluation of synovitis in patients with rheumatoid arthritis. Arthritis Rheum 1994, 37:1151-1157.
50. Stiskal MA, Neuhold A, Szolar DH, et al.: Rheumatoid arthritis of the craniocervical region by MR imaging: detection and characterization. AJR 1995, 165:585-592.
51. Østergaard M, Stoltenberg M, Lovgreen-Nielsen P, et al.: Quantification of synovistis by MRI: correlation between dynamic and static gadolinium-enhanced magnetic resonance imaging and microscopic and macroscopic signs of synovial inflammation. Magn Reson Imaging 1998, 16:743-754.
52. Østergaard M: Different approaches to synovial membrane volume determination by magnetic resonance imaging: manual versus automated segmentation. Br J Rheumatol 1997, 36:1166-1177.
53. Reece RJ, Kraan MC, Radjenovic A, et al.: Comparative Assessment of leflunomide and methotrexate for the treatment of rheumatoid arthritis, by dynamic enhanced magnetic resonance imaging. Arthritis Rheum 2002, 46:366-372. This article offers a good illustration of the potential utility of quantitative MRI in clinical trials of RA.
54. Kraan MC, Reece RJ, Barg EC, et al.: Modulation of inflammation and metalloproteinase expression in synovial tissue by leflunomide and methotrexate in patients with active rheumatoid arthritis: findings in a prospective, randomized, double-blind, parallel-design clinical trial in thirty nine patients at two centers. Arthritis Rheum 2000, 43:1820-1830.
55. Østergaard M, Stoltenberg M, Hendricksen O, et al.: Quantitative assessment of synovial inflammation by dynamic gadolinium-enhanced magnetic resonance imaging. A study of the effect of intra-articular methyl-prednisolone on the rate of early synovial enhancement. Br J Rheumatol 1996, 35:50-59.
56. Kalden-Nemeth D, Grebmeier J, Antoni C, et al.: NMR monitoring of rheumatoid arthritis patients receiving anti-TNF-alpha monoclonal antibody therapy. Rheumatol Int 1997, 16:249-255.
57. Lee J, Lee S, Suh J, et al.: Magnetic resonance imaging of the wrist in defining remission of rheumatoid arthritis. J Rheumatol 1997, 24:1303-1308.
58. Huh YM, Suh JS, Jeong EK, et al.: Role of the inflamed synovial volume of the wrist in defining remission of rheumatoid arthritis with gadolinium-enhanced 3D-SPGR MR imaging. J Magn Reson Imaging 1999, 10:202-208.
59. Peterfy CG: Scratching the surface: articular cartilage disorders in the knee. MRI Clin N Am 2000, 8:409-429.
60. Disler D: Fat-suppressed three-dimensional spoiled gradient-recalled MR imaging: assessment of articular and physeal hyaline cartilage. AJR 1997, 169:1117-1123.
61. Recht MP, Pirraino DW, Paletta GA, et al.: Accuracy of fat-suppressed three-dimensional spoiled gradient-echo FLASH MR imaging in the detection of patellofemoral articular cartilage abnormalities. Radiology 1996, 198:209-212.
62. Bredella M, Tirman P, Peterfy C, et al.: Accuracy of T2-weighted fast spinecho MR imaging with fat saturation in detecting cartilage defects in the knee: comparison with arthroscopy in 130 patients. Am J Roentgenol 1999, 172:1073-1080.
63. Peterfy CG, van Dijke CF, Janzen DL, et al.: Quantification of articular cartilage in the knee by pulsed saturation transfer and fat-suppressed MRI: optimization and validation. Radiology 1994, 192:485-491.
64. Bashir A, Gray ML, Hartke J, et al.: Nondistructive imaging of human cartilage glycosaminoglycan concentration by MRI. Magn Reson Med 1999, 41:857-865.
65. Burstein D, Gray ML, Hartman AL, et al.: Diffusion of small solutes in cartilage as measured by nuclear magnetic resonance (NMR) spectroscopy and imaging. J Orthop Res 1993, 11:465-478.
66. Rubens DJ, Blebea JS, Totterman SM, et al.: Rheumatoid arthritis: evaluation of wrist extensor tendons with clinical examination versus MR imaging: a preliminary report. Radiology 1993, 187:831-838.
67. Valeri G, Ferrara C, Ercolani P, et al.: Tendon involvement in rheumatoid arthritis of the wrist: MRI findings. Skeletal Radiol 2001, 30:138-143.
68. Backhaus M, Kamradt D, Sandrock D, et al.: Arthritis of the finger joints: A comprehensive approach comparing conventional radiography, scintigraphy, ultrasound and contest-enhanced magnetic resonance imaging. Arthritis Rhem 1999, 42:1232-1245.
69. Wakefield RJ, Gibbon WW, Conaghan PG, et al.: The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis. Arthritis Rheum 2000, 3:2762-2770.
70. Grassi W, Filippucci E, Farina A, et al.: Sonographic imaging of the distal phalanx. Semin Arthritis Rheum 2000, 29:379-384.
71. Grassi W, Filippucci E, Farina A, et al.: Ultrasonography in the evaluation of bone erosions. Ann Rheum Dis 2001, 60:98-103.
72. Carotti M, Salaffi F, Manganelli P, et al.: Power Doppler sonography in the assessment of synovial tissue of the knee joint in rheumatoid arthritis: a preliminary experience. Ann Rheum Dis 2002, 61:877-882.
73. Szkudlarek M, Court-Payen M, Strandberg C, et al.: Power Doppler ultrasonography for assessment of synovitis in the metacarpophalangeal joints of patients with rheumatoid arthritis. Arthritis Rheum 2001, 44:2018-2023.
74. Stone M, Bergin D, Whelan B, et al.: Power Doppler ultrasound assessment of rheumatoid arthritis hand synovitis. J Rheumatol 2001, 28:1979-1982.
75. Klauser A, Frauscher F, Schirmer M, et al.: The value of contrast-enhanced color Doppler ultrasound in the detection of vascularization of finger joints in patients with rheumatoid arthritis. Arthritis Rheum 2002, 46:647-653.
76. Walther M, Harms H, Krenn V, et al.: Synovial tissue of the hip at power Doppler US: correlation between vascularity and power Doppler US signal. Radiology 2002, 225:225-231.
77. Walther M, Harms H, Krenn V, et al.: Correlations of power Doppler ultrasonography with the vascularity of the synovial tissue of the knee joint in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 2001, 44:331-338.
78. Peterfy CG: Magnetic resonance imaging of rheumatoid arthritis: the evolution of clinical applications through clinical trials. Semin Arthritis Rheum 2001, 30(6):375-396.
79. Peterfy CG: Magnetic resonance imaging of the wrist in rheumatoid arthritis. Semin Musculoskelet Radiol 2001, 5(3):275-287.